99 related articles for article (PubMed ID: 9398690)
21. Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia.
Calaciura F; Motta RM; Miscio G; Fichera G; Leonardi D; Carta A; Trischitta V; Tassi V; Sava L; Vigneri R
J Clin Endocrinol Metab; 2002 Jul; 87(7):3209-14. PubMed ID: 12107226
[TBL] [Abstract][Full Text] [Related]
22. Genetics and phenomics of hypothyroidism due to TSH resistance.
Persani L; Calebiro D; Cordella D; Weber G; Gelmini G; Libri D; de Filippis T; Bonomi M
Mol Cell Endocrinol; 2010 Jun; 322(1-2):72-82. PubMed ID: 20083154
[TBL] [Abstract][Full Text] [Related]
23. TSH and bone loss.
Sun L; Davies TF; Blair HC; Abe E; Zaidi M
Ann N Y Acad Sci; 2006 Apr; 1068():309-18. PubMed ID: 16831931
[TBL] [Abstract][Full Text] [Related]
24. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
Porcellini A; Ruggiano G; Pannain S; Ciullo I; Amabile G; Fenzi G; Avvedimento EV
Oncogene; 1997 Aug; 15(7):781-9. PubMed ID: 9266964
[TBL] [Abstract][Full Text] [Related]
25. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
26. [TSH affects bone metabolism. Surprising skeletal changes in genetically modified mice].
Lindstedt G
Lakartidningen; 2004 Feb; 101(6):476-7. PubMed ID: 15004943
[No Abstract] [Full Text] [Related]
27. Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity.
Ho SC; Van Sande J; Lefort A; Vassart G; Costagliola S
Endocrinology; 2001 Jul; 142(7):2760-7. PubMed ID: 11415994
[TBL] [Abstract][Full Text] [Related]
28. Thyrotropin receptor messenger ribonucleic acid is expressed in most brown and white adipose tissues in the guinea pig.
Roselli-Rehfuss L; Robbins LS; Cone RD
Endocrinology; 1992 Apr; 130(4):1857-61. PubMed ID: 1547715
[TBL] [Abstract][Full Text] [Related]
29. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
30. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the intact thyrotropin receptor in a human thyroid carcinoma cell line.
Namba H; Yamashita S; Usa T; Kimura H; Yokoyama N; Izumi M; Nagataki S
Endocrinology; 1993 Feb; 132(2):839-45. PubMed ID: 8381075
[TBL] [Abstract][Full Text] [Related]
32. Upon thyrotropin binding the thyrotropin receptor is internalized and localized to endosome.
Singh SP; McDonald D; Hope TJ; Prabhakar BS
Endocrinology; 2004 Feb; 145(2):1003-10. PubMed ID: 14576174
[TBL] [Abstract][Full Text] [Related]
33. Resistance to thyrotropin and other abnormalities of the thyrotropin receptor.
Refetoff S; Sunthornthepvarakul T; Gottschalk ME; Hayashi Y
Recent Prog Horm Res; 1996; 51():97-120; discussion 120-2. PubMed ID: 8701094
[No Abstract] [Full Text] [Related]
34. Suppression of thyrotropin receptor-G protein-phospholipase C coupling by activation of protein kinase C in thyroid carcinoma cells.
Broecker M; Mayr GW; Derwahl M
Endocrinology; 1997 Sep; 138(9):3787-96. PubMed ID: 9275066
[TBL] [Abstract][Full Text] [Related]
35. Thyrotropin (TSH)-induced receptor internalization in nonthyroidal cells transfected with a human TSH-receptor complementary deoxyribonucleic acid.
Heldin NE; Gustavsson B; Hermansson A; Westermark B
Endocrinology; 1994 May; 134(5):2032-6. PubMed ID: 8156904
[TBL] [Abstract][Full Text] [Related]
36. Palmitoylation of human thyrotropin receptor: slower intracellular trafficking of the palmitoylation-defective mutant.
Tanaka K; Nagayama Y; Nishihara E; Namba H; Yamashita S; Niwa M
Endocrinology; 1998 Feb; 139(2):803-6. PubMed ID: 9449658
[TBL] [Abstract][Full Text] [Related]
37. Pituitary-thyroid feedback in a patient with a sporadic activating thyrotropin (TSH) receptor mutation: implication that thyroid-secreted factors other than thyroid hormones contribute to serum TSH levels.
Gelwane G; de Roux N; Chevenne D; Carel JC; Léger J
J Clin Endocrinol Metab; 2009 Aug; 94(8):2787-91. PubMed ID: 19454581
[TBL] [Abstract][Full Text] [Related]
38. Single strand DNA-binding proteins and thyroid transcription factor-1 conjointly regulate thyrotropin receptor gene expression.
Shimura H; Shimura Y; Ohmori M; Ikuyama S; Kohn LD
Mol Endocrinol; 1995 May; 9(5):527-39. PubMed ID: 7565801
[TBL] [Abstract][Full Text] [Related]
39. Thyrotropin-receptor mutations and thyroid dysfunction.
Utiger RD
N Engl J Med; 1995 Jan; 332(3):183-5. PubMed ID: 7800013
[No Abstract] [Full Text] [Related]
40. Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas.
Jaeschke H; Mueller S; Eszlinger M; Paschke R
Clin Endocrinol (Oxf); 2010 Dec; 73(6):815-20. PubMed ID: 20846293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
